Does non-steroidal anti-inflammatory drugs-related preemptive analgesia modulate SOCS3/IL-6 pathway in oral surgery?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Inflammopharmacology - 32(2024), 2 vom: 12. Feb., Seite 1017-1024 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Albuquerque, Assis Filipe Medeiros [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Cytokines |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s10787-024-01433-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055479189 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055479189 | ||
| 003 | DE-627 | ||
| 005 | 20240411064651.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240411s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10787-024-01433-y |2 doi | |
| 035 | |a (DE-627)SPR055479189 | ||
| 035 | |a (SPR)s10787-024-01433-y-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Albuquerque, Assis Filipe Medeiros |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Does non-steroidal anti-inflammatory drugs-related preemptive analgesia modulate SOCS3/IL-6 pathway in oral surgery? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 650 | 4 | |a Preemptive analgesia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Third molar |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ibuprofen |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Etoricoxib |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Real-time polymerase chain reaction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cytokines |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a do Nascimento Costa, José Jackson |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, José Roberto Viana |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Paulo Goberlânio de Barros |e verfasserin |4 aut | |
| 700 | 1 | |a Chaves, Filipe Nobre |e verfasserin |4 aut | |
| 700 | 1 | |a Maferano, Eduardo Frederico Eduardo |e verfasserin |0 (orcid)0009-0004-4182-1881 |4 aut | |
| 700 | 1 | |a Filho, Edson Luiz Cetira |e verfasserin |4 aut | |
| 700 | 1 | |a Pereira, Karuza Maria Alves |e verfasserin |4 aut | |
| 700 | 1 | |a Santiago, Sérgio Lima |e verfasserin |4 aut | |
| 700 | 1 | |a Ribeiro, Thyciana Rodrigues |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Fábio Wildson Gurgel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Inflammopharmacology |d Springer International Publishing, 1991 |g 32(2024), 2 vom: 12. Feb., Seite 1017-1024 |w (DE-627)SPR013448595 |w (DE-600)2047989-X |x 1568-5608 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2024 |g number:2 |g day:12 |g month:02 |g pages:1017-1024 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10787-024-01433-y |m X:VERLAG |x 0 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.38 |q VZ |
| 951 | |a AR | ||
| 952 | |d 32 |j 2024 |e 2 |b 12 |c 02 |h 1017-1024 | ||